Clinical Trials Browser

Recruiting × Gliosarcoma × pembrolizumab × Clear all

NCT05465954 2026-01-12

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

Phase 2 Recruiting

Glioblastoma, Gliosarcoma